Astronaut loading animation Circular loading bar

Try : Insurtech, Application Development

AgriTech(1)

Augmented Reality(20)

Clean Tech(5)

Customer Journey(12)

Design(35)

Solar Industry(6)

User Experience(55)

Edtech(10)

Events(34)

HR Tech(2)

Interviews(10)

Life@mantra(11)

Logistics(5)

Strategy(17)

Testing(9)

Android(47)

Backend(30)

Dev Ops(7)

Enterprise Solution(27)

Technology Modernization(2)

Frontend(28)

iOS(43)

Javascript(15)

AI in Insurance(35)

Insurtech(63)

Product Innovation(49)

Solutions(19)

E-health(10)

HealthTech(22)

mHealth(5)

Telehealth Care(4)

Telemedicine(5)

Artificial Intelligence(132)

Bitcoin(8)

Blockchain(19)

Cognitive Computing(7)

Computer Vision(8)

Data Science(17)

FinTech(50)

Banking(7)

Intelligent Automation(26)

Machine Learning(47)

Natural Language Processing(14)

expand Menu Filters

InsurTalks Podcast with Deepak Singhvi: Covid-19 & the Disruption in Supply Chain Management

7 minutes, 14 seconds read

The outbreak of pandemic Covid-19 has disrupted global supply chains and international trade. Social Distancing norms and restrictions on cross-border travel have made supply chain management extremely difficult. This has set off a chain reaction where many small and medium industries have been hit. 

To discuss the impact of COVID-19 pandemic on the supply chain and how technology can help create better supply chain flow during and post-pandemic, we interviewed Mr. Deepak Singhvi from SAP.

Mr. Deepak Singhvi is a Software Architect for SAP Ariba; where he steers designs and solutions for B2B E-procurement marketplace. Deepak has more than 15 years of experience in Big Data, Analytics, and platform development for various industries like e-commerce, banking, and semiconductor. 

Connect with Mr. Deepak Singhvi – LinkedIn

Excerpt from the interview-

SCM Challenges

What are some of the challenges organizations are facing due to disruption in global supply chains?

Mr. Deepak: We can gauge from the current situation how this pandemic is different from the outbreak of SARS in 2002. That time, China was contributing around 4% of the world’s total GDP and now China contributes somewhere between 18%- 20%. China is like the world’s factory which is present in every aspect of the business and production process. China is manufacturing for the world. 

In the post-pandemic world, we will have to adapt to the volatile environment. Especially, the continuous change in consumer behavior is creating a Bullwhip effect which is troubling the manufacturers. This effect makes it difficult for them to estimate inventories, plan production, set logistics in place, etc. The impact is going to be huge mainly because of China’s major contribution towards world GDP.

Is money also a challenge for the organizations in the supply chain?

Mr. Deepak: Money is an issue, maybe not for big companies. However, for SMEs and startups, who are also contributing to the supply chain, cash liquidity has been a concern. They need to maintain cash liquidity by reducing their operating costs and plan for short-term needs. 

Many governments have introduced provisions for SMEs and start-ups like the Government of India through Small Industries Development Bank of India (SIDBI), France has announced a 4 billion euros package, Germany has introduced a 2 billion euros package and so on. 

Small scale industries need working capital/short-term capital/short-term cash liquidity. Manufacturing units will have to ensure that they have enough supplies because they are somehow surviving this quarter. But, in the next quarter, they’ll have difficulty putting together everything in place. 

Role of Technology in Supply Chain Management 

As per a March survey conducted by the ‘Institute For Supply Chain Management’, nearly 75 percent of companies reported supply chain disruptions due to coronavirus-related transportation restrictions — how is technology going to address these concerns moving forward?

Mr. Deepak: Technology will play a very important role in Supply Chain Management. We need to understand the kinds of problems that are there and how technology can solve it. There are three dimensions to it. 

First is Cost. The USA and many other countries moved their manufacturing units to China three decades ago. That time, Supply Chain was mostly about Cost —  how to reduce cost and improve operational efficiency.

Second is Risk. In the past 5-10 years, another factor has come into place — Risk. Government tariffs and restrictions had a huge impact on the supply chain. It is difficult to import goods from China as there was a lot of opposition to it. 

Third is Resilience. The outbreak of pandemic COVID-19 tested the resilience of organizations to the disruption. 

It if was only about cost, a single human could have managed the cost by taking the assistance of tools and technology. But with increasing dimensions, humans alone cannot manage it. Therefore, technology is helping humans in holistic and better decision making. The supply chain dimensions will keep on increasing and will get more complex. Hence, technology will be important to adapt to the dynamic environment. 

AR and VR in Supply Chain

Do you see technologies like AR & VR playing a greater role in the procurement process?

Mr. Deepak: Technologies such as Augmented Reality and Virtual Reality will help enhance the User Experience. Social Distancing will be in practice for a long time. People might not get the same in-person experience as before. Therefore, AR and VR can help provide a similar experience to their customers. Moreover, these technologies will help significantly in the Customer Support function. VR can help in employee training and real-time assistance in manufacturing plants or offices. There will be a wider application of these technologies in various business units across different industries.

[Also read – 25 Disruptive AR Use Cases]

AI and Automation in Supply Chain Management

How does AI-based technologies like Machine Learning, Automation play a role in supply chain management? Is the investment in AI still relevant for enterprises during this Pandemic crisis?

Mr. Deepak: Artificial Intelligence will be needed more than ever. As the dimensions — apart from Cost, risk and Resilience will increase, it will create a need for an Intelligence System which can use rule-based computing. The system should be able to handle the effects of the bullwhip and enable automatic stock verification. AI will have a bigger role in developing Supply Chain solutions in the New Normal to automate manual operations and increase operational efficiency for Business Continuity

What are the main pain points in supply chain management which AI technologies or automation can address?

Mr. Deepak: Today, most of the systems and processes are in place. Suppliers and Buyers can collaborate on a system. Even SAP Ariba has a Supplier Collaboration platform. Everything works seamlessly under normal circumstances and there are intelligent solutions that make the Supply Chain a bit more flexible. 

Technology can automate manual collaborations. Normal rule-based decision making works most of the time but now we need more complex decision making. Systems need to consider external factors of COVID-19 such as disruption in any specific country or manufacturing plants. These factors can act as inputs to enable better decision-making.

Supply Chain in the New Normal

What lessons can you share for buyers and suppliers operating in the New Normal?

Mr. Deepak: One of the important lessons we learn here is to keep innovating. We need to introduce technologies like AI, AR, VR, RPA, etc. to automate manual processes wherever possible. 

Employees need to be trained in new technologies. Stakeholders need to get ready for the change. Those collaborating on systems should make their systems more agile. Also, businesses need to plan their cash flows to survive in the long term. 

The Future of Personalization

The growth of ‘web content management systems’ is driven by the demand of organizations to deliver personalized content and increase the interactions with customers present online — what does the future of personalization look like?

Mr. Deepak: We have been seeing personalized content for the past couple of years now. There are two aspects to this.

First, in the current situation, we need some kind of personalization. Companies that are ready to deliver personalized content will make a mark for themselves. Whereas, those who were not ready for it will be left behind. 

Second, in the post-pandemic world, many new people will be using digital platforms for the first time. They need better experiences that go beyond the traditional way of buying and selling. The companies that will add personalization into their products and services will have an edge over those who don’t. 

Start-ups in the Post-Pandemic World

It will be a survival issue for the start-ups for the next 1-2 years. Which sectors should start-ups focus their technological innovations which could add value not just to them but society at large?

Mr. Deepak: Many start-ups have been hit due to this pandemic. But now they need to evaluate whether to continue in the existing line of business or make a shift to an area where there’s opportunity in the post-pandemic world. 

The technology-led business model will be critical. It will have a key role in defining strategies. Start-ups have opportunities in the area of security and performance engineering as more people are working from home creating gaps in the data security. We are learning many lessons from this pandemic. They are reinforcing and validating our current model of getting out of the global crisis. There is a scope of growth as long as we keep building innovative solutions. 

In a nutshell

In this session, Mr. Deepa Singhvi shared his insights on technology innovations needed in the time of this crisis for start-ups and how supply chains can be improved through a new set of technologies like AI, AR, VR, and automation in the post-pandemic world. 

Podcasts in this series:

Cancel

Knowledge thats worth delivered in your inbox

Embracing the Digital Frontier: Transforming the Patient Journey in Pharma

In the realm of pharmaceuticals, the digital revolution is not just a buzzword; it’s a seismic shift reshaping the landscape of patient care. From discovery to delivery, digital technologies are revolutionizing every facet of the pharmaceutical industry. One of the most profound impacts is evident in the patient journey. Today’s Patients are more informed, engaged, and empowered than ever, thanks to the proliferation of digital tools and platforms. In this comprehensive exploration, we will delve into the multifaceted ways digital is redefining the patient journey in pharmaceuticals.

According to a report by Accenture on the rise of digital health, these are the key challenges to overcome:

  • 99% of respondents indicated that the development and commercialization of Digital Health solutions has accelerated in the past two years. As part of this, companies require various new and strengthened capabilities to execute their visions. 
  • Patients and health professionals need to trust that the data collected is accurate, safe, and secure for them to feel comfortable using it. 
  • Fragmented data or lack of access to data has been a barrier to development. An overarching guideline on data privacy is needed.

Leveraging Digital Solutions for Accessible Drug Delivery

In the pharmaceutical industry, the journey of medication from production facilities to patients’ hands is evolving with the integration of digital solutions. These technologies not only streamline logistics but also ensure that medications reach even the most remote and underserved areas. Let’s delve into how digital innovations are transforming drug delivery and backend channels in the pharmaceutical industry.

Digital Backend Channels and Supply Chain Management:

Pharmaceutical firms leverage digital tech for efficient backend operations. Software like SAP Integrated Business Planning and Oracle SCM Cloud enable real-time tracking, inventory management, and demand forecasting. With AI and analytics, companies adapt to market changes swiftly, ensuring timely medication delivery and optimized supply chain logistics.

Innovative Digital Drug Delivery Technologies:

  1. Controlled Monitoring Systems: Digital temperature monitoring systems provide digital temperature monitoring solutions using IoT sensors and cloud platforms, safeguarding temperature-sensitive medications during transit, ensuring compliance with regulatory standards, and minimizing product spoilage risk.
  1. Last-Mile Delivery Platforms: Zipline and Nimblr.ai, along with LogiNext, employ digital last-mile delivery solutions, using drones and AI-powered logistics to transport vital medical supplies efficiently to remote regions, improving accessibility for underserved communities.
  1. Telemedicine Integration with Prescription: Integrated telemedicine and prescription platforms, like Connect2Clinic, are rapidly growing in response to COVID-19. With telehealth claims at 38 times pre-pandemic levels, the industry is projected to hit $82 billion by 2028, with a 16.5% annual growth rate. Mantra Labs partnered with Connect2Clinic, enabling seamless coordination between healthcare providers, pharmacies, and patients. This facilitates virtual consultations and electronic prescribing, benefiting remote patients with medical advice and prescriptions without in-person visits. These platforms enhance healthcare access, medication adherence, and patient engagement through personalized care plans and reminders.
  1. Community Health Worker Apps: CommCare and mHealth empower community health workers with digital tools for medication distribution, education, and patient monitoring. Customizable modules enable tracking inventories, health assessments, and targeted interventions, extending pharmaceutical reach to remote communities, and ensuring essential medications reach those in need.

Through the strategic deployment of digital solutions in drug delivery and backend channels, pharmaceutical companies are overcoming barriers to access and revolutionizing healthcare delivery worldwide. By embracing innovation and collaboration, they are not only improving patient outcomes but also advancing toward a more equitable and inclusive healthcare system.

Personalized Medicine:

Wearable devices and mobile apps enable personalized medicine by collecting real-time health data and tailoring treatment plans to individual needs. For example, fitness trackers monitor activity and vital signs, customizing exercise and medication. Personalized medicine optimizes efficacy, minimizes adverse effects, and enhances patient satisfaction by leveraging patient-specific data.

Enhanced Patient Engagement:

Pharmaceutical firms utilize digital platforms for patient engagement, fostering support and education during treatment. Through social media, mobile apps, and online communities, patients connect, access resources, and receive professional support. Two-way communication enhances collaboration and decision-making, boosting treatment adherence, health outcomes, and consumer loyalty. Click here to know more.

Data-Driven Insights:

The abundance of healthcare data offers pharma companies unique opportunities to understand patient behavior and treatment patterns. By leveraging big data analytics and artificial intelligence, they extract actionable insights from various sources like electronic health records and clinical trials. These insights inform targeted marketing, product development, and patient support programs. However, ensuring data privacy and security is crucial, requiring robust regulatory frameworks and transparent practices in the digital era.

Challenges and Considerations:

Maximizing the benefits of digital technologies requires addressing challenges like patient data privacy and equitable access to healthcare tech. Stringent safeguards are needed to protect confidentiality and trust, alongside efforts to bridge the digital divide. Regulatory frameworks must evolve to balance innovation with patient safety and security amidst rapid advancements in digital health.

Key Considerations for Pharma Companies in Embracing Digital Innovation:

  • Prioritize patient-centricity in digital initiatives, focusing on improving patient outcomes and experiences.
  • Invest in robust data privacy and security measures to build and maintain patient trust.
  • Foster collaboration and partnerships with technology companies and healthcare providers to drive innovation and scalability.
  • Leverage analytics and AI to derive actionable insights from healthcare data and inform decision-making processes.
  • Continuously monitor and adapt to regulatory requirements and industry standards to ensure compliance and mitigate risks.

Conclusion:

The digital revolution is not just a paradigm shift but a catalyst for transformation across the pharmaceutical industry. By embracing digital technologies, pharma companies can unlock new opportunities to enhance the patient journey, improve treatment outcomes, and drive sustainable growth. However, realizing the full potential of digital health requires collaboration, innovation, and a steadfast commitment to addressing the challenges and considerations inherent in this transformative journey. As we navigate the digital frontier, the future of patient care promises to be more connected, personalized, and empowering than ever before.

Cancel

Knowledge thats worth delivered in your inbox

Loading More Posts ...
Go Top
ml floating chatbot